BioXcel Therapeutics, Inc.: Clinical stage company utilizing AI technology platform to identify improved therapies in neuroscience and immuno-oncology. BXCL501 (sublingual dexmedetomidine): Phase 3 trials ongoing for the acute treatment of agitation in patients with schizophrenia (SERENITY I) and bipolar disorder (SERENITY II). Topline data expected mid-2020; Phase 1b/2 trial (TRANQUILITY) ongoing for the acute treatment of agitation associated with geriatric dementia. Data expected mid-2020; BXCL701 (innate immunity activator): Phase 1b/2 ongoing of BXCL701 and KEYTRUDA for Prostate Cancer (tNEPC).
Sector/industry:
Healthcare/Biotechnology
Characteristics:
Based in...
US - New England
Clinical Stage
Phase III, Phase l or ll
Disease Space
Central Nervous System, Oncology
Industry
Biotechnology
Listing
Public, USA
Market Cap
1B +
Therapeutic Modalities
Platform Technology, Small Molecule
Website:
Address:
555 Long Wharf Drive
5th Floor
New Haven, Connecticut 06511
United States

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Top 10 Holders of BioXcel Therapeutics, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
DNCA Finance SA 5.70 892,453 47.67 Stakes 2020-03-03
Artemis Investment Management LLP 5.02 786,958 42.04 13F 2020-03-31
Ikarian Capital LLC 4.43 693,716 37.06 13F 2020-03-31
Fidelity Management & Research Co. LLC 3.86 605,490 32.35 13F 2020-03-31
The Vanguard Group, Inc. 3.22 504,899 26.97 Funds 2020-05-31
Vanguard Group, Inc. (Subfiler) 3.03 475,102 25.38 13F 2020-03-31
Acuta Capital Partners LLC 2.01 315,000 16.83 13F 2020-03-31
Driehaus Capital Management LLC 1.91 299,932 16.02 13F 2020-03-31
Massachusetts Financial Services Co. 1.75 274,404 14.66 13F 2020-03-31
BlackRock Fund Advisors 1.58 247,319 13.21 13F 2020-03-31
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.